Metabolon Names Andrew Messick Chief Financial Officer
Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon’s next stage of growth Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the appointment of Andrew (Drew) Messick as Chief Financial Officer. […]